相关实验视频
Updated: Jun 25, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
80.7K
埃塞俄比亚结核病诊断技术的成本效益:一个建模研究
Lelisa Fekadu Assebe1,2, Andargachew Kumsa Erena3, Lemmessa Fikadu4
1Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway. lelfekadu1@gmail.com.
Cost effectiveness and resource allocation : C/E
|May 22, 2024
概括
埃塞俄比亚的X-pert MTB/RIF测试是埃塞俄比亚结核病 (TB) 最具成本效益的快速诊断工具,显著改善了早期检测和治疗结果. 这一发现支持增加资金用于更广泛的实施,以减少结核病负担.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 传染病诊断 传染病诊断 传染病诊断
背景情况:
- 结核病 (TB) 构成了严重的公共卫生威胁,特别是在埃塞俄比亚等高流行率国家.
- 早期诊断和治疗对于控制结核病至关重要,国家指南建议快速诊断.
- 关于埃塞俄比亚各种诊断工具的效率的证据有限.
研究的目的:
- 评估埃塞俄比亚结核病和多抗药结核病 (TB/MDR-TB) 快速诊断工具的成本效益.
- 为了比较X-pert MTB/RIF,Truenat,胸部X射线查,TB-LAMP和涂抹显微镜的效率.
主要方法:
- 一个混合马尔科夫模型是为一组假定结核病病例开发的.
- 评估成本效益的方法是使用每个因残疾调整的寿命年 (DALYs) 避免的增量成本.
- 数据来源于二次数据,从卫生系统的角度进行分析和概率敏感性分析.
主要成果:
- X-pert MTB/RIF表现出高成本效益,其增量成本效益比 (ICER) 为每天276美元.
- 胸部X射线查之后的X-pert MTB/RIF成本效益较低 (ICER:每DALY避免1666美元).
- 实施X-pert MTB/RIF预计将在10,000名结核病患者中预防9600个DALY.
结论:
- 埃塞俄比亚X-pert MTB/RIF是埃塞俄比亚结核病最具成本效益的诊断工具.
- 它的使用增强了早期检测和治疗,改善了患者的治疗结果.
- 增加X-pert MTB/RIF的资金可以减少结核病检测差距,提高整体治疗成功率.
更多相关视频
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis III
322
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
322
Pulmonary Tuberculosis I
234
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
234
Pneumonia III: Complications and Assessment
202
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
202

